Weekly Care Review: Who Handles Your GLP-1 Care, Prescription and Delivery?

01One website, several responsible parties

Weekly Care LLC owns and operates the website, according to its privacy policy. Its terms draw a clear boundary around that company’s role: Weekly Care connects registered users with products, healthcare professionals and pharmacies, rather than providing medical care or advice itself. That distinction matters if a question concerns prescribing rather than an order. The organization processing a payment or answering a shipping email is not necessarily the organization responsible for deciding whether treatment is appropriate.

The homepage identifies David Wasef, MD, as Wasef Health’s founder and medical director and says Weekly Care partners with Wasef Health to provide access to licensed medical professionals. Those professionals review health information, determine treatment and provide ongoing care. These are website representations, not independently verified credentials. Our guide to clinicians and telehealth platforms explains why identifying the treating practice is a practical step, not just a matter of reading corporate disclosures.

The terms also place medical-record responsibility with the treating provider. Weekly Care says it does not maintain the medical records created during care; requests for copies must go directly to that provider. Before enrolling, a prospective patient can therefore ask for the treating practice’s name, its clinical contact route and its records-request process. Having those details makes the division of responsibilities usable if care later needs to move elsewhere.

02From intake to a clinical decision

The documented pathway begins with an online medical intake. An independent provider reviews the information and may prescribe if the person is an appropriate candidate; completing intake does not guarantee a prescription. The terms limit access to adults 18 or older located in the United States, with possible additional age restrictions for particular products. Although the homepage advertises all-state availability, it also says care is delivered by professionals licensed where the patient is located and that state-specific options can differ. Weekly Care’s tirzepatide page also says not to use compounded tirzepatide with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a serious allergy to tirzepatide or any formulation ingredient, or during pregnancy, planned pregnancy or breastfeeding. These restrictions require discussion with the treating clinician.

Telehealth access requires a separate electronically signed informed consent. Weekly Care’s terms acknowledge that telehealth is not suitable for every medical condition and does not always replace an in-person evaluation. Its semaglutide page asks patients to provide a complete medical history and a list of prescription medicines, over-the-counter products, vitamins and supplements. Those requests describe information the clinician needs; they do not establish that every applicant can be evaluated entirely through a questionnaire.

The consulted documentation does not establish a Weekly Care-specific BMI admission rule, required laboratory schedule or standard consultation format. The refund policy refers to consultations conducted live or by message, but that does not guarantee a choice between formats. Before paying, ask what encounter is planned, whether testing could be required, who orders it and whether any laboratory charges are separate. These unresolved details affect both the time to a decision and the practical cost of obtaining care.

03Confirm the product before the pharmacy handoff

Weekly Care advertises Compounded Semaglutide+ and Compounded Tirzepatide+. The individual product pages describe subcutaneous injection, not oral treatment. However, the consulted pages do not identify what the plus sign adds, the exact formulation a particular patient would receive or the quantity supplied under the advertised monthly price. A useful prepayment request is therefore a written description of the prescribed preparation, its presentation, included supplies and dispensing pharmacy—not merely confirmation of the ingredient name.

The homepage says Weekly Care works with licensed 503A compounding pharmacies, naming Hallandale Pharmacy and VialsRx as examples. Its descriptions of oversight and quality are provider claims, not independent pharmacy verification in this review. The terms allow prescriptions to be filled and transferred among network pharmacies, with patient notification. They also permit certain prescriptions to go to a pharmacy of the patient’s choice, although that changes responsibility for obtaining and paying for the medication.

FDA guidance supplies an important boundary: compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. That status alone does not prove clinical inequivalence or establish the quality of a particular provider. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Our pharmacy-handoff guide offers a framework for clarifying the specific product and responsible dispenser.

04What the starting price includes—and what it leaves open

The homepage advertises compounded semaglutide starting at $89 per month and compounded tirzepatide starting at $99 per month, stating the same price at every dose. It says prescribed medication, provider visits, supplies, two-day shipping and ongoing support are included, with no separate monthly membership or provider fees. Those are meaningful advertised inclusions. They are not, however, a complete checkout quotation: the pages do not explain the commitment, prepayment arrangement or supply quantity needed to obtain either starting price.

Weekly Care operates on a self-pay basis and does not bill insurance. It says HSA or FSA reimbursement may be available depending on the individual plan, which is not a reimbursement guarantee. The terms also create a significant pharmacy-channel exception: someone using an outside pharmacy must obtain the product and pay that pharmacy directly. The advertised medication-inclusive arrangement should therefore not be assumed to cover an independently selected dispenser on identical financial terms.

Some products or services use automatically renewing subscriptions, with charging intervals disclosed during checkout. Separately, the cancellation policy discusses six-month plans without documenting their full price, billing schedule or dispensing schedule. A six-month plan reference does not establish six months of medication delivered at once or a universal minimum commitment. Before authorizing payment, obtain the first charge, subsequent charge, billing interval and actual supply period in writing, along with any testing costs not addressed by the advertised inclusions.

05Approval, dispatch and arrival run on different clocks

The homepage promotes provider review in one day and delivery in one to two days, alongside a two-day-shipping message. It qualifies those timelines as estimates dependent on medical review, prescription approval, pharmacy processing, availability and shipping conditions. The operational policy gives a different planning reference: medication generally ships within two to four business days following provider approval and pharmacy preparation. That is a dispatch window, not a promise that treatment arrives two to four days after intake.

Orders are fulfilled Monday through Friday, with no shipping on weekends or US federal holidays. The policy describes expedited transport such as UPS 2nd Day Air or a comparable service. Tracking arrives by email when the order ships and may take up to 24 hours to activate. Reading these statements together is more useful than treating the shortest advertised interval as the whole journey. Our explanation of approval, dispatch and arrival separates the stages that can otherwise be mistaken for one deadline.

06Delivery problems require prompt action

Weekly Care’s policy sets short reporting windows. A damaged package must be reported to help@weekly.care within 24 hours of delivery, with a clear photograph and retained packaging. After verification, the company offers replacement or refund; requests outside the window may not be honored. A shipment marked delivered but not received also requires notice within 24 hours and supporting documentation, such as a missing-package claim. If theft is suspected, a police report may be required before replacement is considered.

The policy says melted ice packs, packaging variations or outdoor temperature changes alone do not qualify for refund or replacement unless Weekly Care or the pharmacy determines medication integrity was compromised. That commercial standard must be distinguished from FDA’s use advice: do not use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contact the provider or dispensing pharmacy. A decision about reimbursement is not permission to use a questionable shipment. The warm-delivery guide explains that distinction.

07Ongoing care is promised, but its cadence is not defined

Weekly Care advertises continuing care from its partner medical team and administrative support seven days a week for orders, shipments and related questions. Its privacy policy says communication with healthcare providers occurs exclusively through the HIPAA-governed patient portal. These are different contact functions: seven-day administrative availability does not establish seven-day clinician coverage, a clinical response deadline or access to a physician at any particular hour. The consulted pages also do not confirm Spanish-language clinical care or interpretation.

The documentation does not specify scheduled follow-up intervals, required monitoring, clinical renewal frequency or laboratory requirements and costs. NIDDK describes follow-up as a matter of treatment response and tolerability, not simply continuing payments. FDA also reports measurement and administration errors involving compounded GLP-1 products and advises clarifying instructions with the prescriber or pharmacist. Weekly Care’s tirzepatide page warns that oral contraceptives may be less effective, particularly when starting treatment and after each dose increase, and advises people using birth control pills to speak with their provider before starting. Before starting, ask who explains the dispensed presentation, where clinical questions go and how a concern is handled while awaiting a portal response.

08Stopping renewal is different from canceling an order

To end a plan, the cancellation policy directs patients to email help@weekly.care. Once confirmed, the plan remains active through the current billing cycle and further renewals stop; unused time does not receive partial or prorated refunds. The terms also allow subscription pause requests. For a six-month plan with at least three months remaining, cancellation does not automatically qualify for a refund: Weekly Care decides at its discretion whether to refund the unused portion. These provisions make written confirmation important.

Order cancellation follows a separate boundary. After a live or message consultation, the policy allows cancellation for a refund before the medication order is submitted to the pharmacy. Once the prescription is transmitted, ordinary cancellation and refund are unavailable. If the clinician finds the person medically ineligible, the policy promises order cancellation and a full refund. Delays or communication problems do not automatically qualify for refunds, while confirmed duplicate charges and billing errors do.

Refund requests are reviewed within two to four business days. Approved refunds are returned to the original payment method within five to ten business days, with additional time possible for the bank or card issuer to post the credit. These are not guaranteed bank-receipt deadlines. The policy displays an effective and last-updated date of September 9, 2026; that label does not independently establish which version will govern a future purchase. Save the checkout terms and confirm how they apply to the chosen plan.

Questions & answers

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
2. NIDDK: prescription medications for overweight and obesity ↗
3. Weekly Care — shipping and refund ↗
4. Weekly Care — terms and conditions ↗
5. Weekly Care — privacy policy ↗
6. Weekly Care — official website ↗
7. Weekly Care — safety compounded semaglutide ↗
8. Weekly Care — safety compounded tirzepatide ↗

Continue reading

• The GLP-1 Care Journey: Who Handles Intake, Prescribing, Delivery and Follow-Up?
• Who Provides Your Care When You Use a Telehealth Platform?
• From Prescription to Dispensing: Questions for the GLP-1 Pharmacy Handoff
• GLP-1 Approval, Dispatch and Arrival Are Different Clocks
• When Injectable Medicine Arrives Warm: Reading the FDA Advice